The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Menjugate 10 micrograms suspension for injection Meningococcal group C conjugate vaccine



GSK Vaccines S.r.l.PA0919/004/004

Main Information

Trade NameMenjugate 10 micrograms suspension for injection Meningococcal group C conjugate vaccine
Active SubstancesMeningococcal group c oligosaccharide
Corynebacterium diphtheriae crm197 protein
Dosage FormSuspension for injection
Licence HolderGSK Vaccines S.r.l.
Licence NumberPA0919/004/004

Group Information

ATC CodeJ07AH Meningococcal vaccines
J07AH05 other meningococcal polyvalent purified polysaccharides antigen

Status

License statusAuthorised
Licence Issued08/05/2015
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back